EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: Radiotherapy and Oncology, 123, Suppl. 1, S. S740-S741

Event
Veröffentlichung
(where)
Augsburg
(who)
Universität Augsburg
(when)
2017
Event
Veröffentlichung
(who)
Elsevier BV
(when)
2017
Creator
Peters, S.
Christiaens, M.
Schulz, S.
Frisch, S.
Kramer, P. H.
Blase, C.
Frühwald, Michael
Timmermann, B.

DOI
10.1016/s0167-8140(17)31817-0
URN
urn:nbn:de:bvb:384-opus4-728937
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Peters, S.
  • Christiaens, M.
  • Schulz, S.
  • Frisch, S.
  • Kramer, P. H.
  • Blase, C.
  • Frühwald, Michael
  • Timmermann, B.
  • Universität Augsburg
  • Elsevier BV

Time of origin

  • 2017

Other Objects (12)

BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors

BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors

Bridging molecular advancements and clinical challenges in pediatric oncology

Bridging molecular advancements and clinical challenges in pediatric oncology

Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus

Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus

Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor

Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor

Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup

Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup

Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors

Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors

Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors

Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors

Radiation therapy plays an important role in the treatment of atypical teratoid/rhabdoid tumors: analysis of the EU-RHAB cohorts and their precursors

Radiation therapy plays an important role in the treatment of atypical teratoid/rhabdoid tumors: analysis of the EU-RHAB cohorts and their precursors

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases

Limbic encephalitis with LGI1 antibodies in a 14-year-old boy

Limbic encephalitis with LGI1 antibodies in a 14-year-old boy

Suboccipital Extraspinal Extracranial Atypical Teratoid Rhabdoid Tumor

Suboccipital Extraspinal Extracranial Atypical Teratoid Rhabdoid Tumor

Related objects